pentobarbital will minimize the level or impact of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Use of different treatment options is strongly suggested when linagliptin would be to be administered which has a CYP3A4 inducerpentobarbital will reduce the extent or outcome of cannabidiol by impacting hepa